BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//AssetMemo//Readout calendar//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:HBI-002 readouts · AssetMemo
X-WR-CALDESC:Upcoming readouts of HBI-002\, from ClinicalTrials.gov estimat
 es.
REFRESH-INTERVAL;VALUE=DURATION:PT12H
X-PUBLISHED-TTL:PT12H
BEGIN:VEVENT
UID:NCT07005180-1654@assetmemo.bio
DTSTAMP:20261121T005717Z
DTSTART;VALUE=DATE:20261231
DTEND;VALUE=DATE:20270101
SUMMARY:HBI-002: Phase 2 readout est. (NCT07005180)
DESCRIPTION:HBI-002\, phase 2\, Parkinson's Disease.\nStudy: Low-dose Carbo
 n Monoxide (HBI-002) Trial to Evaluate Safety\, Tolerability\, PK\, and Bi
 omarkers in Parkinson's Disease\nEstimated primary completion: 31 December
  2026. This is a ClinicalTrials.gov estimate\, not a confirmed readout dat
 e\, and it can move.\nDrug page: https://assetmemo.bio/drug/hbi-002#upcomi
 ng-events\nRegistry record: https://clinicaltrials.gov/study/NCT07005180
URL:https://assetmemo.bio/drug/hbi-002#upcoming-events
TRANSP:TRANSPARENT
END:VEVENT
END:VCALENDAR
